Skip to Main Content

Author Details

Kurt W Fisher
University of Nebraska Medical Center
2004
39
17
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36572584Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature.Clin Lymphoma Myeloma Leuk2023
37972068SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status.Proc Natl Acad Sci U S A2023
37924938Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.Cancer Lett2023
35203041Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients.Int Immunopharmacol2022
36474183Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma.BMC Cancer2022
35994501Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice.PLoS One2022
36230802PGC-1β and ERRα Promote Glutamine Metabolism and Colorectal Cancer Survival via Transcriptional Upregulation of PCK2.Cancers (Basel)2022
35313765Pulmonary Tumor Embolism and Pulmonary Tumor Thrombotic Microangiopathy Causing Rapidly Progressive Respiratory Failure: A Case Series.J Investig Med High Impact Case Rep2022
33970103KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.Elife2021
33120942A Gene Expression High-Throughput Screen (GE-HTS) for Coordinated Detection of Functionally Similar Effectors in Cancer.Cancers (Basel)2020
31848187The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response.Clin Cancer Res2020
31728622MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer.Radiat Environ Biophys2020
31964871High-throughput identification of protein functional similarities using a gene-expression-based siRNA screen.Sci Data2020
30629587ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.PLoS One2019
31687226Ciliated Hepatic Foregut Cyst: A Report of a Case Incidentally Discovered during Transplant Evaluation.Case Rep Gastrointest Med2019
31378711A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery.Cell Chem Biol2019
30425122RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications.J Clin Pathol2019
28720476Atypical appearance of a rectal Dieulafoy lesion.Gastrointest Endosc2018
29850292Use of Endoscopic Ultrasound in a Diagnostic Dilemma: Metastatic Breast Cancer to the Stomach.Case Rep Gastrointest Med2018
29925347WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.BMC Cancer2018
29491475A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.Sci Rep2018
28782638Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.Hum Pathol2018
27500376TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer.Mol Carcinog2017
28333549KSR as a therapeutic target for Ras-dependent cancers.Expert Opin Ther Targets2017
29026529Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras.F1000Res2017
28709933Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.J Proteomics2017
26891728Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer.Mol Diagn Ther2016
27273865KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.Mol Cell Biol2016
25547910Molecular foundations for personalized therapy in prostate cancer.Curr Drug Targets2015
26351140AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.Mol Cell Biol2015
26338658Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus.Future Oncol2015
26604636MicroRNA in inflammatory bowel disease: Translational research and clinical implication.World J Gastroenterol2015
26125428Drug-Induced Liver Injury.Arch Pathol Lab Med2015
25002533Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation.Mol Cell Biol2014
24129700Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.Sci Signal2013
21518958Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.Mol Cell Biol2011
19883615KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.Cell Metab2009
16645180Transcriptional regulation of lung cytidylyltransferase in developing transgenic mice.Am J Respir Cell Mol Biol2006
15139854Transcriptional repression of the CTP:phosphocholine cytidylyltransferase gene by sphingosine.Biochem J2004
  • 1 - 39 of 39

Recommended Authors

Moores Cancer Center, University of California
Career Start Year 2015
Number of shared co-authors 1
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 1996
Number of shared co-authors 0
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 0
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 0
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 2

Collaborators

University of Nebraska Medical Center
Co-authored papers 17
University of Georgia
Co-authored papers 7
Seoul National University
Co-authored papers 5
University of California
Co-authored papers 4
UT Southwestern Medical Center
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
University of Texas Southwestern Medical Center
Co-authored papers 2
The First Affiliated Hospital of Guangdong Pharmaceutical University
Co-authored papers 1
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
University Hospital Zurich
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
The University of Texas Southwestern Medical Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Co-authored papers 1
Universidad Autonoma de San Luis Potosi
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute-Frederick
Co-authored papers 1
Virginia Commonwealth University
Co-authored papers 1
UT Southwestern Medical Center
Co-authored papers 1
Quantitative Biomedical Research Center
Co-authored papers 1
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Broad Institute of Harvard and MIT
Co-authored papers 1